Skip to main content
Equibles

Sio Capital Management, LLC

Position in XLO — Xilio Therapeutics, Inc.

CIK 1482416 NEW YORK, NY
Back to XLO Full portfolio

Position in XLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,460,605
+$178,383 QoQ
Shares Held
152,464
0.0% QoQ
Ownership
2.64%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#7
of 26 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sio Capital Management, LLC holds $224,951,128 across 32 Biotechnology names. XLO ranks #28 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALLO
Allogene Therapeutics, Inc.
 13,323,431 $27,712,736
2 TYRA
Tyra Biosciences, Inc.
 695,315 $22,208,361
3 IDYA
IDEAYA Biosciences, Inc.
 480,383 $17,903,874
4 ORKA
Oruka Therapeutics, Inc.
 177,118 $16,856,320
5 RAPP
Rapport Therapeutics, Inc.
 307,657 $12,820,067
6 CELC
Celcuity Inc.
 110,022 $11,510,501
7 REGN
Regeneron Pharmaceuticals, Inc.
 18,000 $11,223,720
8 VIR
Vir Biotechnology, Inc.
 1,075,274 $10,957,042

All Filings in XLO

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,460,605 152,464
2026-03-31 $1,282,222 152,464
2025-12-31 $1,366,103 2,134,537